Idefirix

Medicinal product

(Invented) name

Idefirix

Active substance (s)

Imlifidazė

Strength

11 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AA41, imlifidase

Marketing authorisation holder

Hansa Biopharma AB, Švedija

Date of authorisation

2020-08-25

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Imlifidazė	11 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104949	91050	1091050	flakonas	N1		Receptinis	EU/1/20/1471/001	Netiekiama	-	-	No	-	-
104950	91051	1091051	flakonas	N2		Receptinis	EU/1/20/1471/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-08-25	Registruotas